Danese, Silvio
Danese, Silvio
ROMA - Istituto di medicina interna e geriatria
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
2024 Danese, Silvio; Panaccione, Remo; Feagan, Brian G; Afzali, Anita; Rubin, David T; Sands, Bruce E; Reinisch, Walter; Panés, Julián; Sahoo, Aparna; Terry, Natalie A; Chan, Daphne; Han, Chenglong; Frustaci, Mary Ellen; Yang, Zijiang; Sandborn, William J; Hisamatsu, Tadakazu; Andrews, Jane M; D'Haens, Geert R; Gasbarrini, Antonio; GALAXI-1 Study, Group
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study
2023 Solitano, Virginia; Facheris, Paola; Petersen, Magnus; D'Amico, Ferdinando; Ortoncelli, Michela; Aletaha, Daniel; Olivera, Pablo A; Bieber, Thomas; Ramiro, Sofia; Ghosh, Subrata; D'Agostino, Maria Antonietta; Siegmund, Britta; Chary-Valckenaere, Isabelle; Hart, Ailsa; Dagna, Lorenzo; Magro, Fernando; Felten, Renaud; Kotze, Paulo Gustavo; Jairath, Vipul; Costanzo, Antonio; Kristensen, Lars Erik; Biroulet, Laurent Peyrin; Danese, Silvio
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
2023 Lopetuso, Loris Riccardo; Deleu, Sara; Godny, Lihi; Petito, Valentina; Puca, Pierluigi; Facciotti, Federica; Sokol, Harry; Ianiro, Gianluca; Masucci, Luca; Abreu, Maria; Dotan, Iris; Costello, Samuel Paul; Hart, Ailsa; Iqbal, Tariq H; Paramsothy, Sudarshan; Sanguinetti, Maurizio; Danese, Silvio; Tilg, Herbert; Cominelli, Fabio; Pizarro, Theresa T; Armuzzi, Alessandro; Cammarota, Giovanni; Gasbarrini, Antonio; Vermeire, Séverine; Scaldaferri, Franco
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study.
2022 Papa, A; Scaldaferri, F; Covino, M; Tursi, A; Furfaro, F; Mocci, G; Lopetuso, Lr; Maconi, G; Bibbò, S; Fiorani, M; Laterza, L; Mignini, I; Napolitano, D; Parisio, L; Pizzoferrato, M; Privitera, G; Pugliese, D; Schepis, T; Schiavoni, E; Settanni, Cr; Vetrone, Lm; Armuzzi, A; Danese, S; Gasbarrini, A.
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy
2021 Privitera, Giuseppe; Pugliese, Daniela; Onali, Sebastiano; Petito, Valentina; Scaldaferri, Franco; Gasbarrini, Antonio; Danese, Silvio; Armuzzi, Alessandro
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy
2021 Privitera, G.; Pugliese, D.; Onali, S.; Petito, V.; Scaldaferri, F.; Gasbarrini, A.; Danese, S.; Armuzzi, A.
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease
2021 Olivera, P. A.; Zuily, S.; Kotze, P. G.; Regnault, V.; Al Awadhi, S.; Bossuyt, P.; Gearry, R. B.; Ghosh, S.; Kobayashi, T.; Lacolley, P.; Louis, E.; Magro, F.; Ng, S. C.; Papa, Alfredo; Raine, T.; Teixeira, F. V.; Rubin, D. T.; Danese, Silvio; Peyrin-Biroulet, L.
Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: an Italian consensus statement
2021 Graffigna, Guendalina; Bosio, Caterina; Pagnini, Francesco; Volpato, Eleonora; Previtali, Enrica; Leone, Salvatore; D’Amico, Ferdinando; Armuzzi, Alessandro; Danese, Silvio
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease
2020 Privitera, Giuseppe; Onali, Sara; Pugliese, Daniela; Renna, Sara; Savarino, Edoardo; Viola, Antonella Anna Paola; Ribaldone, Davide Giuseppe; Buda, Andrea; Bezzio, Cristina; Fiorino, Gionata; Fantini, Massimo Claudio; Scaldaferri, Franco; Guidi, Luisa; Danese, Silvio; Gasbarrini, Antonio; Orlando, Ambrogio; Armuzzi, Alessandro
Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery
2020 Papa, A; Tursi, A; Danese, S; Rapaccini, G; Gasbarrini, A; Papa, V
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer
2019 Tacconi, C; Ungaro, Francesco; Correale, C; Arena, Vincenzo; Massimino, L; Detmar, M; Spinelli, Adriano; Carvello, M; Mazzone, Marinella; Oliveira, Ai; Rubbino, F; Garlatti, V; Spano, S; Lugli, E; Colombo, Fs; Malesci, A; Peyrin-Biroulet, L; Vetrano, S; Danese, Silvio; D'Alessio, S
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study
2018 Mangili, G; Cioffi, Rosanna; Danese, Silvio; Frigerio, L; Ferrandina, Maria Gabriella; Cormio, G; Rabaiotti, E; Scarfone, G; Gadducci, A; Bergamini, A; Pisano, C; Candiani, M
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
2017 Colombel, Jf; Panaccione, R; Bossuyt, P; Lukas, M; Baert, F; Vanasek, T; Danalioglu, A; Novacek, G; Armuzzi, Alessandro; Hebuterne, X; Travis, S; Danese, Silvio; Reinisch, W; Sandborn, Wj; Rutgeerts, P; Hommes, D; Schreiber, S; Neimark, E; Huang, Bd; Zhou, Q; Mendez, P; Petersson, J; Wallace, K; Robinson, Am; Thakkar, Rb; D'Haens, G
Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting
2017 Allocca, M.; Landi, R.; Bonovas, S.; Fiorino, G.; Papa, A.; Spinelli, A.; Furfaro, F.; Peyrin-Biroulet, L.; Armuzzi, A.; Danese, S.
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine
2015 Sala, E; Genua, M; Petti, L; Anselmo, A; Arena, Vincenzo; Cibella, J; Zanotti, L; D'Alessio, S; Scaldaferri, Franco; Luca, Gi; Arato, I; Calafiore, R; Sgambato, Alessandro; Rutella, Sergio; Locati, M; Danese, Silvio; Vetrano, S.
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing
2015 Scaldaferri, Franco; Sofo, Luigi; Rapaccini, Gian Ludovico; Danese, Silvio; Gasbarrini, Antonio
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing.
2015 Papa, Alfredo; Papa, Valerio; Marzo, Manuela; Scaldaferri, Franco; Sofo, Luigi; Rapaccini, Gian Ludovico; Danese, Silvio; Gasbarrini, Antonio
Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment
2015 Quetglas, Emilio Garcia; Armuzzi, Alessandro; Wigge, S; Fiorino, Gionata; Barnscheid, L; Froelich, M; Danese, Silvio
Ruolo dei fattori psicologici nelle malattie infiammatorie croniche intestinali
2015 Menichetti Delor, Julia Paola; Leone, Daniela; Fiorino, Gionata; Gilardi, Daniela; Borghi, Lidia; Lamiani, Giulia; Allocca, Mariangela; Delliponti, Mariangela; Alfieri, Marina Francesca; Danese, Silvio; Vegni, Elena
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation
2015 Genua, Marco; D'Alessio, Silvia; Cibella, Javier; Gandelli, Alessandro; Sala, Emanuela; Correale, Carmen; Spinelli, Antonino; Arena, Vincenzo; Malesci, Alberto; Rutella, Sergio; Ploplis, Victoria A.; Vetrano, Stefania; Danese, Silvio
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2024 | Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial | Danese, Silvio; Panaccione, Remo; Feagan, Brian G; Afzali, Anita; Rubin, David T; Sands, Bruce E; Reinisch, Walter; Panés, Julián; Sahoo, Aparna; Terry, Natalie A; Chan, Daphne; Han, Chenglong; Frustaci, Mary Ellen; Yang, Zijiang; Sandborn, William J; Hisamatsu, Tadakazu; Andrews, Jane M; D'Haens, Geert R; Gasbarrini, Antonio; GALAXI-1 Study, Group | |
| 1-gen-2023 | Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study | Solitano, Virginia; Facheris, Paola; Petersen, Magnus; D'Amico, Ferdinando; Ortoncelli, Michela; Aletaha, Daniel; Olivera, Pablo A; Bieber, Thomas; Ramiro, Sofia; Ghosh, Subrata; D'Agostino, Maria Antonietta; Siegmund, Britta; Chary-Valckenaere, Isabelle; Hart, Ailsa; Dagna, Lorenzo; Magro, Fernando; Felten, Renaud; Kotze, Paulo Gustavo; Jairath, Vipul; Costanzo, Antonio; Kristensen, Lars Erik; Biroulet, Laurent Peyrin; Danese, Silvio | |
| 1-gen-2023 | The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease | Lopetuso, Loris Riccardo; Deleu, Sara; Godny, Lihi; Petito, Valentina; Puca, Pierluigi; Facciotti, Federica; Sokol, Harry; Ianiro, Gianluca; Masucci, Luca; Abreu, Maria; Dotan, Iris; Costello, Samuel Paul; Hart, Ailsa; Iqbal, Tariq H; Paramsothy, Sudarshan; Sanguinetti, Maurizio; Danese, Silvio; Tilg, Herbert; Cominelli, Fabio; Pizarro, Theresa T; Armuzzi, Alessandro; Cammarota, Giovanni; Gasbarrini, Antonio; Vermeire, Séverine; Scaldaferri, Franco | |
| 1-gen-2022 | Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. | Papa, A; Scaldaferri, F; Covino, M; Tursi, A; Furfaro, F; Mocci, G; Lopetuso, Lr; Maconi, G; Bibbò, S; Fiorani, M; Laterza, L; Mignini, I; Napolitano, D; Parisio, L; Pizzoferrato, M; Privitera, G; Pugliese, D; Schepis, T; Schiavoni, E; Settanni, Cr; Vetrone, Lm; Armuzzi, A; Danese, S; Gasbarrini, A. | |
| 1-gen-2021 | Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy | Privitera, Giuseppe; Pugliese, Daniela; Onali, Sebastiano; Petito, Valentina; Scaldaferri, Franco; Gasbarrini, Antonio; Danese, Silvio; Armuzzi, Alessandro | |
| 1-gen-2021 | Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy | Privitera, G.; Pugliese, D.; Onali, S.; Petito, V.; Scaldaferri, F.; Gasbarrini, A.; Danese, S.; Armuzzi, A. | |
| 1-gen-2021 | International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease | Olivera, P. A.; Zuily, S.; Kotze, P. G.; Regnault, V.; Al Awadhi, S.; Bossuyt, P.; Gearry, R. B.; Ghosh, S.; Kobayashi, T.; Lacolley, P.; Louis, E.; Magro, F.; Ng, S. C.; Papa, Alfredo; Raine, T.; Teixeira, F. V.; Rubin, D. T.; Danese, Silvio; Peyrin-Biroulet, L. | |
| 1-gen-2021 | Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: an Italian consensus statement | Graffigna, Guendalina; Bosio, Caterina; Pagnini, Francesco; Volpato, Eleonora; Previtali, Enrica; Leone, Salvatore; D’Amico, Ferdinando; Armuzzi, Alessandro; Danese, Silvio | |
| 1-gen-2020 | Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease | Privitera, Giuseppe; Onali, Sara; Pugliese, Daniela; Renna, Sara; Savarino, Edoardo; Viola, Antonella Anna Paola; Ribaldone, Davide Giuseppe; Buda, Andrea; Bezzio, Cristina; Fiorino, Gionata; Fantini, Massimo Claudio; Scaldaferri, Franco; Guidi, Luisa; Danese, Silvio; Gasbarrini, Antonio; Orlando, Ambrogio; Armuzzi, Alessandro | |
| 1-gen-2020 | Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery | Papa, A; Tursi, A; Danese, S; Rapaccini, G; Gasbarrini, A; Papa, V | |
| 1-gen-2019 | Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer | Tacconi, C; Ungaro, Francesco; Correale, C; Arena, Vincenzo; Massimino, L; Detmar, M; Spinelli, Adriano; Carvello, M; Mazzone, Marinella; Oliveira, Ai; Rubbino, F; Garlatti, V; Spano, S; Lugli, E; Colombo, Fs; Malesci, A; Peyrin-Biroulet, L; Vetrano, S; Danese, Silvio; D'Alessio, S | |
| 1-gen-2018 | Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study | Mangili, G; Cioffi, Rosanna; Danese, Silvio; Frigerio, L; Ferrandina, Maria Gabriella; Cormio, G; Rabaiotti, E; Scarfone, G; Gadducci, A; Bergamini, A; Pisano, C; Candiani, M | |
| 1-gen-2017 | Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial | Colombel, Jf; Panaccione, R; Bossuyt, P; Lukas, M; Baert, F; Vanasek, T; Danalioglu, A; Novacek, G; Armuzzi, Alessandro; Hebuterne, X; Travis, S; Danese, Silvio; Reinisch, W; Sandborn, Wj; Rutgeerts, P; Hommes, D; Schreiber, S; Neimark, E; Huang, Bd; Zhou, Q; Mendez, P; Petersson, J; Wallace, K; Robinson, Am; Thakkar, Rb; D'Haens, G | |
| 1-gen-2017 | Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting | Allocca, M.; Landi, R.; Bonovas, S.; Fiorino, G.; Papa, A.; Spinelli, A.; Furfaro, F.; Peyrin-Biroulet, L.; Armuzzi, A.; Danese, S. | |
| 1-gen-2015 | Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine | Sala, E; Genua, M; Petti, L; Anselmo, A; Arena, Vincenzo; Cibella, J; Zanotti, L; D'Alessio, S; Scaldaferri, Franco; Luca, Gi; Arato, I; Calafiore, R; Sgambato, Alessandro; Rutella, Sergio; Locati, M; Danese, Silvio; Vetrano, S. | |
| 1-gen-2015 | Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing | Scaldaferri, Franco; Sofo, Luigi; Rapaccini, Gian Ludovico; Danese, Silvio; Gasbarrini, Antonio | |
| 1-gen-2015 | Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. | Papa, Alfredo; Papa, Valerio; Marzo, Manuela; Scaldaferri, Franco; Sofo, Luigi; Rapaccini, Gian Ludovico; Danese, Silvio; Gasbarrini, Antonio | |
| 1-gen-2015 | Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment | Quetglas, Emilio Garcia; Armuzzi, Alessandro; Wigge, S; Fiorino, Gionata; Barnscheid, L; Froelich, M; Danese, Silvio | |
| 1-gen-2015 | Ruolo dei fattori psicologici nelle malattie infiammatorie croniche intestinali | Menichetti Delor, Julia Paola; Leone, Daniela; Fiorino, Gionata; Gilardi, Daniela; Borghi, Lidia; Lamiani, Giulia; Allocca, Mariangela; Delliponti, Mariangela; Alfieri, Marina Francesca; Danese, Silvio; Vegni, Elena | |
| 1-gen-2015 | The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation | Genua, Marco; D'Alessio, Silvia; Cibella, Javier; Gandelli, Alessandro; Sala, Emanuela; Correale, Carmen; Spinelli, Antonino; Arena, Vincenzo; Malesci, Alberto; Rutella, Sergio; Ploplis, Victoria A.; Vetrano, Stefania; Danese, Silvio |